Physician's First Watch

Physician's First Watch

Medical news from NEJM Journal Watch

September 6, 2017

By Joe Elia

Edited by David G. Fairchild, MD, MPH

Intensive blood-pressure lowering among hypertensive patients with moderate- to late-stage kidney disease is associated with lower all-cause mortality, a meta-analysis finds....

Comments (0)

September 5, 2017

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

The FDA has cleared for marketing a two-dimensional digital mammography system that allows patients to adjust the amount of compression to their breasts...

Comments (0)

By the Editors

The American Academy of Pediatrics has issued its recommendations on influenza vaccination for the 2017–18 flu...

Comments (0)

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

Newer rapid diagnostic tests for influenza — namely, digital immunoassays (DIAs) and rapid nucleic acid amplification tests (NAATs) — are more sensitive than traditional rapid flu tests, according to a...

Comments (0)

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

A reanalysis of U.S. and European data seems to offer more support for prostate-specific antigen (PSA)-based screening for prostate cancer. The findings appear in the Annals of Internal Medicine.

Researchers reexamined data from the European Randomized Study of Screening for Prostate Cancer, which originally showed a reduction...

Comments (0)

September 2, 2017

September 1, 2017

By Kelly Young

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

The majority of patients with low-risk papillary thyroid cancer don't experience tumor growth within 5 years, making active surveillance a safe option, suggests...

Comments (0)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Findings from a JAMA Pediatrics meta-analysis support selective serotonin reuptake inhibitors (SSRIs) and cognitive behavioral therapy (CBT) for the treatment of childhood...

Comments (0)

August 31, 2017

By Kristin J. Kelley

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM

The FDA has approved a new combinationdrug — meropenem-vaborbactam — to treat adults with...

Comments (0)

By the Editors

The FDA has approved benznidazole to treat Chagas disease, a parasitic infection, in children aged 2 to 12 years.

The disease...

Comments (0)

By Kelly Young

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM

Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine inhibitors (SNRIS) work somewhat better than placebo in treating psychiatric disorders among children and adolescents, according to...

Comments (0)

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM

The FDA on Wednesday approved tisagenlecleucel (Kymriah) for patients up to age 25 years with B cell precursor acute lymphoblastic leukemia that has relapsed or not responded...

Comments (0)

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM

Liraglutide — a glucagon-like peptide 1 (GLP-1) agonist — lowers risks for kidney disease in patients with type 2 diabetes, according to a secondary analysis from an...

Comments (0)

August 30, 2017

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

A longer duration of breast-feeding is associated with a lower risk for endometriosis in the mother, according to a study in...

Comments (0)

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

St. Jude Medical's (now Abbott's) implantable cardiac pacemakers have been recalled...

Comments (0)

By the Editors

Here are some of the latest offerings from NEJM Group:

NEJM Clinical Practice Center: Image in clinical medicine: A 52-year-old woman who was taking immunosuppressive therapy...

Comments (0)

Pages